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Abstract
The aim of this work was to investigate the microbial causes, incidence, duration, risk fac-
tors and clinical implications of bacteraemia occurring during transurethral resection of the
prostate (TURP) surgery to better inform prophylaxis strategies. An ethically approved, pro-
spective, cohort study of patients undergoing TURP was conducted. Clinical information
and follow-up details were collected using standardized data collection sheets. Blood was
obtained for culture at 6 different time points peri-procedure. Standard of care antibiotic pro-
phylaxis was given prior to surgery. Bacteriuria was assessed in a pre-procedure urine sam-
ple. Histopathology from all prostate chips was assessed for inflammation and malignancy.
73 patients were consented and 276 blood samples obtained. No patients developed symp-
tomatic bacteraemia during the procedure, 17 patients developed asymptomatic bacterae-
mia (23.2%). Enterococcus faecalis and Pseudomonas aeruginosa were the most common
organisms cultured. 10 minutes after the start of the TURP, the odds ratio (OR) of develop-
ing bacteraemia was 5.38 (CI 0.97–29.87 p = 0.05), and 20 minutes after the start of the pro-
cedure, the OR was 6.46 (CI 1.12–37.24, p = 0.03), compared to before the procedure. We
also found an association between the development of intra-operative bacteraemia and
recent antibiotic use (OR 4.34, CI 1.14–16.62, p = 0.032), the presence of a urinary catheter
(OR 4.92, CI 1.13–21.51, p = 0.034) and a malignant histology (OR 4.90, CI 1.30–18.46,
p = 0.019). There was no statistical relationship between pre-operative urine culture results
and blood culture results. This study shows that asymptomatic bacteraemia is commonly
caused by TURP and occurs in spite of antibiotic prophylaxis. Our findings challenge the
commonly held view that urine is the primary source of bacteraemia in TURP-associated
sepsis and raise the possibility of occult prostatic infection as a cause of bacteraemia. More
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work will be needed to determine the significance of transient bacteraemia in relation to
more serious complications like infective endocarditis and malignancy.
Introduction
Transurethral resection of the prostate (TURP) is a common operation (150, 000 per year in
US) and is associated with a significant infective morbidity. Reported rates of bacteraemia fol-
lowing TURP without antimicrobial prophylaxis vary widely (0–31%), but decrease to 1% with
antimicrobial prophylaxis[1,2]. Anecdotes of severe sepsis following TURP are common[3]
and we have recently shown an association between urological procedures and an increased
risk of enterococcal endocarditis[4]. A better understanding these infective complications is
necessary to design effective prevention and treatment strategies.
Few studies have been specifically designed to assess the frequency and implications of bac-
teraemia related to TURP; most studies report bacteriuria, urinary tract infections (UTIs) and
fever. Only if patients were clinically suspected to have a bacteraemia (e.g. fever or rigors), were
blood cultures then taken to determine the presence of bacteraemia. The rate of asymptomatic
bacteraemia in TURP patients is not known; only a few old studies, with design limitations,
have addressed the issue [5–8].
All major urology guidelines recommend the use of antimicrobial prophylaxis during a
TURP[9–11]. However, antimicrobial prophylaxis is used to decrease the incidence of post-
operative bacteriuria, rather than other significant infective parameters such as bacteraemia,
bloodstream infection or severe sepsis[12–14]. Urological instrumentation is associated
with enterococcal endocarditis, (~1 in 4200 procedures), [4] however, it is still not known
why some patients develop such severe infective episodes whilst others have an uneventful
procedure. It is not known if prostate pathology affects the risk of serious infective
complications.
The primary aim of the study was to investigate the incidence, timing, duration and identity
of bacteraemia or bloodstream infection occurring during TURP. A secondary aim was to
investigate the patient (e.g. underlying prostatic disease) and procedure-related risk factors
associated with the development of peri-operative bacteraemia during TURP.
Materials and Methods
Ethics
Ethics approval was obtained from the Leeds West research ethics committee (REC number:
10/H1307/5) and institutional approval was also obtained(R&D number: UR09/9173). All
patient gave written consent to participate in the study.
Study design, inclusion and exclusion criteria
For the primary aim, a prospective, cohort study design was undertaken on patients having
TURP at our institution. For the secondary aim, a case control design was used where ‘cases’
were those patients who had evidence of bacteraemia and the controls were patients who did
not develop bacteraemia. The study included both catheterised patients undergoing TURP for
acute urinary retention and non-catheterised patients undergoing TURP for lower urinary
tract symptoms (LUTS). Patients with both benign prostatic hyperplasia and known prostatic
adenocarcinoma of the prostate were included in the study.
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Definitions
Bacteraemia was defined as the presence of bacteria in blood, irrespective of the bacterial count
[15]. Bloodstream infection was defined as bacteraemia with clinical signs or symptoms of
infection. Single blood culture isolates of normal skin flora (coagulase-negative staphylococci,
coryneforms) were considered likely contaminants. Bacteriuria was defined as>104 cfu/ml
microorganisms in pure culture.
Study size
Previous articles suggest that the incidence during prostatic surgery is 29–46%, we intended to
undertake a logistic regression analysis in which case a sample size of at least 69 patients would
provide 20 cases—permitting robust analysis for two risk factors.
Setting and surgical considerations
The Leeds Teaching Hospitals NHS Trust is a tertiary referral centre and teaching hospital of
around 2500 beds. It undertakes approximately 250 TURP procedures yearly by 10 urological
surgeons. TURP was carried out under general or spinal anaesthesia. Both monopolar and
bipolar devices were used for the procedure, dependent on the surgeon’s preference. The local
policy for antimicrobial prophylaxis for TURP at our institution was intravenous gentamicin
160mg, within the hour prior to the procedure.
Demographics and clinical variables
A detailed medical history was obtained pre-procedure, using a structured form, to obtain
details of possible risk factors for the development of bacteraemia. The variables collected
included age, weight, recent antimicrobial therapy, immunosuppression, diabetes, smoking,
co-existing infection, recent long hospital stay, recurrent UTIs, urinary catheter and urolithia-
sis. A structured telephone interview was conducted with patients three months after the pro-
cedure to gather data relating to infective complications. The hospital patient pathway
management (PPM) database and the results servers were accessed to confirm the data
obtained at the telephone interview.
Microbiological sampling and processing
Blood sampling. Blood was collected at 5–6 time-points peri-procedure as shown in Fig 1,
with variation depending on urinary catheterisation status pre-procedure. 20ml of blood was
obtained at each time point. 15ml of the blood was transferred into Biomerieux BacT/ALERT1
aerobic and anaerobic bottles (bioMérieux UK Limited, Basingstoke, UK) and all samples were
subcultured after 10 days of incubation at 37°C. Any growth detected on sub-culture was
Fig 1. Schematic representation of data acquired from recruited participants.
doi:10.1371/journal.pone.0157864.g001
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identified using 16S PCR (forward primer: AGAGTTTGATCCTGGCTCAG, reverse primer
CTACG CATTTCACCGCTACAC) as described previously[16].
Urine sampling. Urine samples were plated on blood and CLED agar and incubated at
37.4°C at atmospheric pressure for 24 hours. Bacterial growth detected on agar plates was iden-
tified by 16S PCR[16].
Histopathology
An experienced histopathologist independently reviewed prostate tissue obtained at the TURP
to determine the presence of inflammation and calcification, in addition to the presence of
malignancy, according to criteria set in the report from the International Society of Urologic
Pathology consensus conference[17].
Statistical analysis
Non-normally distributed, continuous variables are presented as median and range and nor-
mally distributed variables, as mean and standard deviations (SD). Pearson’s Chi-Square test
was used to evaluate the association between bacteriuria and bacteraemia (SPSS Version 20.0.0,
IBM Corporation). A multi-level statistical model was designed, using the open source statisti-
cal computing environment, specifically Microsoft R Open 3.2.3 (http://www.r-project.org) to
evaluate whether there was an association between the timing of blood collection and the devel-
opment of bacteraemia (S1 Statistical Model). A complete data set was used for the multiple
regression analysis and the analysis was considered exploratory in nature.
Univariable and multivariable analyses were performed to assess the association between
the possible risk factors for developing bacteraemia and the development of bacteraemia (SPSS




77 patients were screened and 74 of these were consented to participate. One patient was found
to have a bladder tumour intraoperatively and did not proceed with a TURP operation. Fig 2
shows the number of patients available for each step of the analysis. Table 1 shows the demo-
graphics of the 73 patients recruited to the study. Blood samples was obtained from 54 of the
73 patients. A urine sample and prostate histology were available for all 73 patients recruited.
Patient characteristics
Within 2 weeks prior to the TURP, a quarter of patients had received antimicrobial therapy
(n = 18, 24.7%), a UTI (n = 10, 13.7%) or urological instrumentation (n = 3, 4.1%) as shown in
Table 1. Twenty patients (27.3%) had experienced a long inpatient hospital stay within the
three months prior to the procedure for various medical conditions including urological
pathologies. Nine patients (12.3%) had a history of microbiologically confirmed recurrent
UTIs prior to the surgery. Thirty-eight patients (52.1%) had a urinary catheter in situ at the
time of their surgery, with a median duration of the catheterisation being 49 days (range 2
days-12 months). Five patients were performing clean intermittent self catheterization (CISC)
Twenty-nine patients (39.7%) had an underlying cardiac pathology with 21 patients (28.8%)
having a prosthetic device (coronary stents, prosthetic heart valves, pacemakers, joint prosthe-
ses) in situ.
Bacteraemia and TURP
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Fig 2. Participants recruited in the prospective study.
doi:10.1371/journal.pone.0157864.g002
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Incidence, timing, frequency and duration of bacteraemia
No patients developed symptomatic bloodstream infection during the TURP but seventeen
patients (23.3%) were bacteraemic. Table 2 shows the bacterial isolates. Enterococcus faecalis
and Pseudomonas aeruginosa were the most common organisms cultured. Three patients
(4.1%) were bacteremic prior to TURP and ten patients (13.7%) suffered a repeated bacterae-
mia (the recovery of the same organisms on more than one occasion) during the course of the
procedure. Two samples were regarded as contaminants as the organisms detected (Staphylo-
coccus caprae and Corynebacterium glucuronolyticum respectively) are known skin organisms
and were recovered from single blood samples[18].
Statistical modeling showed that bacteraemia was most likely to occur 10 and 20 minutes into
the procedure; at 10 and 20 minutes, bacteraemia was 5.38 and 6.46 times more likely to be
detected respectively, compared to before the start of the procedure (Table 3, S2 Statistical Model).
Although fourteen of the seventeen patients (82.4%) who developed bacteraemia during their pro-
cedure had a urinary catheter in-situ or were performing CISC prior to the procedure, removal of
a urethral catheter prior to instrumentation did not appear to increase the likelihood of developing
bacteraemia (OR: 0.76, CI 0.193–3.01, p = 0.69). A patient who had antimicrobial therapy in the
two weeks prior to a TURP was 4.3 times less likely to develop bacteraemia than a patient who did
not receive antibiotics (OR: 4.34, CI 1.14–16.62 p = 0.032). Having a urinary catheter in situ was
associated with the development of intra-TURP bacteraemia (OR: 4.92, CI 1.13–21.51, p = 0.034).
Bacteriuria
Thirty-four patients (46.6%) had preoperative bacteriuria, with Enterococcus faecalis being the
most common organism cultured (Table 4). Eleven of the thirty-four patients (32.3%) with
Table 1. Demographics of recruited participants having a TURP.
Variable N = 73
Mean age (years) 72.7±8.56
Mean weight (kg) 86.6±15.3
Within 2 weeks prior to TURP Antimicrobial use (%) 18 (24.7)
Urological instrumentation (%) 3 (4.1)
UTI (%) 10 (13.7)
Immunosuppression (%) 2 (2.7)
Diabetes (%) 6 (8.2)
Smoking (%) 8 (11.0)
Co-existing infection (%) 3 (4.1)
Recent extended hospital stay (%) 20 (27.4)
Recurrent UTIs (%) 9 (12.3)
Urolithiasis (%) 4 (5.5)
Urinary catheter (%) 38 (52.1)
Cardiac history Arrhythmia (%) 14 (19.2)
Ischaemic heart disease (%) 13 (17.8)
Valvular Disease 2 (2.7)
Infective endocarditis (%) 0 (0)
Prosthetic device Orthopaedic (%) 12 (16.4)
Cardiovascular (%) 8 (11.0)
Other (%) 1 (1.4)
Organ transplant (%) 0 (0)
doi:10.1371/journal.pone.0157864.t001
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bacteriuria did not have a urinary catheter in situ, although four out of those eleven patients
performed clean intermittent self-catheterisation (CISC) on a regular basis. Statistical concor-
dance between blood and urine isolates was poor (χ2 = 3.74, p = 0.15). However, 6 out of the 17
patients (35.3%) with evidence of bacteremia had the same organism both in blood and urine.
Prostatic pathology
Histopathology showed 20 (27.4%) patients had prostate cancer and 26 (35.6%) had evidence
of prostatic inflammation (23 with chronic inflammation, two with both acute and chronic
inflammation, and one with acute inflammation). Three patients (4.1%) had evidence of pros-
tatic calcification. A patient with a malignant histology was 4.9 times more likely to develop
bacteraemia than a patient with benign histology (OR: 4.90, CI: 1.30–18.46, p = 0.019)
(Table 5, S3 Statistical Model and S1 Raw Data). There was also a statistical association between
the development of intraoperative bacteraemia and prostatic inflammation (χ2 = 4.97,
Table 2. Bacteraemia detected in participants having TURP.
Patient Presence of
catheter
Preoperative urine isolate Identity of bacteraemia Number of positive time
points (n = 39)
Comment
1 No No isolate Staphylococcus caprae 1 Considered
contaminant
2 Yes Corynebacterium amycolatum Actimonyces turicensis 3
2 Yes Enterococcus faecalis + Pseudomonas
aeruginosa
Pseudomonas aeruginosa 2
4 Yes No isolate Staphylococcus epidermidis 1 Considered a
contaminant
5 No (CISC) Enterococcus faecalis Staphylococcus epidermidis 2
6 No (CISC) Klebsiella oxytoca Actinomyces neuii 5
7 No No isolate Actinobaculummassiliense 2




9 Yes Pseudomonas aeruginosa Veillonella dispar 1
10 Yes Proteus mirabilis Proteus vulgaris 5
11 Yes Enterococcus faecalis Enterococcus faecalis 4
12 Yes No isolate Streptococcus anginosus 1
13 Yes Pseudomonas aeruginosa Pseudomonas aeruginosa 3
14 Yes Pseudomonas aeruginosa Pseudomonas aeruginosa 4
15 Yes Enterococcus faecalis Enterococcus faecalis 1
16 Yes No isolate Staphylococcus epidermidis 1 Considered a
contaminant
17 Yes Pseudomonas aeruginosa Streptococcus agalactiae 2
doi:10.1371/journal.pone.0157864.t002
Table 3. Results from linear model to evaluate the association between the timing of the blood sam-
pling and the development of bacteraemia, using pre-procedure rate as the comparator.
Variable Odds ratio 95% Confidence interval p-value
Pre-procedure (A) 1 - -
Urethral catheter removal (B) 0.72 0.08–6.73 0.77
5 minutes into procedure (C) 4.04 0.72–22.53 0.11
10 minutes into procedure (D) 5.38 0.97–29.87 0.05
20 minutes into procedure (E) 6.46 1.12–37.24 0.04
Post-procedure (F) 4.16 0.74–23.25 0.10
doi:10.1371/journal.pone.0157864.t003
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p = 0.026), but we were unable to fit prostatic inflammation into the multivariable model
owing to the multi-level association between antimicrobial use, prostatic malignancy, age and
bacteraemia. The frequency of calcification was too low to detect any statistical association
with intraoperative bacteraemia.
Follow-up
52 patients (71.2%) patients were discharged within two days of the TURP procedure, with
haematuria being the main reason for delay in discharge from the hospital as shown in Table 6.
Two patients had symptoms/signs of systemic infection post TURP requiring antimicrobial
therapy, although there was no intra-procedure bacteraemia in these two patients. The organ-
isms grown in blood cultures, collected during the pyrexial episodes, were Staphylococcus epi-
dermidis (considered a likely contaminant) and Enterococcus faecalis. The preoperative urine
culture for the former grew Staphylococcus hominis while no isolate was retrieved from the
urine sample of the latter. Forty-one patients (56.1%) had a documented bacteriuria within the
three months after the procedure. Forty-three (58.9%) of the recruited patients were contact-
able by telephone for an interview 3 months post procedure. Sixteen (21.9%) complained of
lower urinary tract symptoms post procedure. Thirteen patients (17.8%) were readmitted to
the hospital (Table 6).
Discussion
Understanding the pathogenesis and implications of bacteraemia during TURP is important to
the design of effective preventative measures. We found that bacteraemia was common, affect-
ing 23% of our patients, in spite of antimicrobial prophylaxis. Bacteraemia mostly occurred
after the insertion of the instrument used for resection of the prostate and did not usually last
Table 4. The identity of bacteriuria prior to TURP.
Identity of bacteriuria Number of participants without a urinary catheter Number of participants with a urinary catheter
Enterococcus faecalis 3 7
Pseudomonas aeruginosa 0 5
Escherichia coli 2 2
Coagulase negative Staphylococcus 1 2
Klebsiella oxytoca 2 0
Klebsiella penumoniae 0 2
Corynebacterium amycolatum 0 2
Morganella morganii 1 0
Proteus mirabilis 0 1
Staphylococcus aureus 1 0
Unidentified 0 3
TOTAL (n = 34) 10 24
doi:10.1371/journal.pone.0157864.t004
Table 5. Results frommultivariable analysis to assess the association between the development of bacteraemia and risk factors.
OR 95% C.I. for OR P-value
Lower Upper
Antibiotics Use 4.34 1.13 0.032 16.62
Urethral catheter in situ 4.92 1.13 0.034 21.51
Malignancy on histology 4.90 1.30 0.019 18.46
doi:10.1371/journal.pone.0157864.t005
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for the duration of the procedure. The finding that bacteraemia most often developed between
10 to 20 minutes after the start of the procedure and reduced after the end of the procedure
suggests that there is a causal relationship between TURP and bacteraemia. However, TURP
did not explain the bacteraemia in all patients because some were bacteraemic prior to the start
of the procedure. Ten of the seventeen-bacteraemic patients had persistent bacteraemia during
the resection of the prostate.
We found an association between bacteraemia and prior urinary catheterization, prior anti-
microbial use and malignant histology, but no conclusions about causation can be made. It is
believed that some patient groups, such as those with a urethral catheter in situ pre-operatively
are at increased risk of developing infective episodes post TURP[19]. Whilst the presence of a
urinary catheter pre-operation was a risk factor for bacteraemia, it did not explain all cases and
there was a poor correlation between pre-operative urine culture results and the microorgan-
isms found in the blood. For these reasons we speculate that the source of the bacteraemia
might be the prostate in some cases. Bacteraemia might occur as a consequence of trauma to
the prostate tissue during the resection rather than resulting from the removal of a ‘colonised’
urethral catheter. [20] [21]. While 46.6% of our patients had bacteriuria (with two-thirds of
these patients having a urinary catheter in-situ), there was no concordance between urine cul-
ture results and bacteraemia. Given that the same isolate was retrieved from the urine and
blood of 35.3% of the patients with intra-operative bacteremia, it is possible that some of the
bacteraemias resulted from the prior bacteriuria. This finding was confirmed by Okhawa et al.
who showed that bacteraemia peri-prostatic surgery was more prevalent in patient with pre-
operative bacteriuria than patients with sterile urine (53.7% vs 8.2%)[22]. The association with
previous antibiotic therapy suggests that these patients may have presented with symptoms or
signs of infection before they had surgery.
The bacteraemia was ‘controlled’ in all of the patients in this study; none of the bacteraemic
patients developed symptoms or signs of systemic infection. The lack of patients with blood-
stream infection or severe sepsis in this cohort probably reflects the small sample size and is
consistent with studies of antimicrobial prophylaxis for TURP which reported severe sepsis
and bloodstream infection in 1–5% of cases[8,23,24]. Demonstrating the presence of asymp-
tomatic bacteraemia in patients undergoing TURP in spite of antimicrobial prophylaxis raises
concerns about the relevance of our current prophylaxis regimen. However, we do not know if
the rates of bloodstream infection and severe sepsis would be higher without prophylaxis and
the short duration of bacteraemia in some cases may be influenced by administration of pro-
phylaxis. It is surprising that Pseudomonas aeruginosa was a frequent cause of bacteraemia in
Table 6. Post procedure parameters for participants undergoing TURP.
Parameters from hospital server n = 73
Patients discharged within 2/7 52
Patients with positive MSU within 3 months of procedure 41
Patients with a positive blood culture within 3 month of the procedure 7
Malignant prostate histology 20
Parameters from telephone interview n = 43
Felt unwell 15
Lower urinary tract symptoms 16
Urine sample to GP 15
Antibiotics from GP 15
Readmission (within 3 months) For Infection 7
For other causes 6
doi:10.1371/journal.pone.0157864.t006
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this analysis in spite of use of a prophylactic agent (gentamicin) that would be expected to have
anti-pseudomonal activity. Conversely, it is not surprising that gentamicin did not prevent
enterococcal bacteremia. The long-term effects of this asymptomatic bacteraemia are not
known and we feel that this exploratory study does not provide sufficient evidence to drive a
change in prescribing practice. However, we recently published data demonstrating an associa-
tion between prior urological procedures and the subsequent development of enterococcal
infective endocarditis[4] with an estimated rate of enterococcal IE of fewer than 1 endocarditis
case every 4000 procedures. Several potential endocarditis-causing bacteria isolates were
obtained from blood of the participants in our study. It is possible that inserting an instrument
in the prostate has long-term infective consequences, mediated by a silent bacteraemia, but fur-
ther work would be required to investigate this.
This is the first study to demonstrate an association between prostatic inflammation and
malignancy and bacteraemia during TURP and it suggests that bacteria within the prostate
might be the source of peri-operative bacteraemia, rather than the traditionally held view that
bacteria in urine are responsible. This in turn raises questions about the possible role of chronic
low-grade prostatic infection in prostatic malignancy, a possibility that has been raised before
[25].
There were unexpected microbiological results including repeated isolation of Actinomyces
species in two patients. There is only one report of the association of Actinomyces and prostatic
infection in the literature[26]. We probably recovered these bacteria because of the prolonged
blood culture protocol with routine subcultures. We used this protocol in the research setting
to maximize the sensitivity of the assay as sample processing was blinded to the clinical team
and would not be used to manage patient care. Routine microbiology protocols for blood cul-
tures in the UK (usual incubation is 5–7 days) would not have detected these bacteria. This
finding adds weight to the hypothesis that undiagnosed, chronic low-grade prostatic infection
might have an insidious role in patients with lower urinary tract symptoms or prostatic
malignancy.
Although we have demonstrated asymptomatic bacteraemia during TURP, this is just a
‘snapshot’ of the longitudinal history of the patient. Our results support the role of transure-
thral prostatic surgery as a cause of bacteraemia, but it may be that patients with prostatic
pathology have recurrent asymptomatic bacteraemias, outside the setting of the operating the-
atre. In the context of serious infective complications of TURP, such as IE, the cumulative effect
of recurrent spontaneous bacteraemias might be more important in pathogenesis than the brief
episode in relation to TURP, as has been postulated in the pathogenesis of dental-related IE
[27]. It may be possible that the prostate gland is not a bacteria-free organ in the setting of uro-
logical pathology. Although, there are a few studies looking at culture of prostate chips and
biopsies, newer methodologies like PCR and electron microscopy may help shed light on
whether bacteria resides in or on the prostate and whether they reside as colonies or biofilms
that are hard to culture[21].
Though this is the largest series to date to assess bacteraemia in TURP patients, the results
may not be applicable to the general population undergoing TURP because the sample size is
small. We recruited to target, but found the incidence of bacteraemia to be lower than expected,
reducing the power to investigate risk factors. The authors acknowledge it would have been
useful to evaluate other variables (e.g prostate chip culture), but this only became apparent at
the end of the study. The wide confidence intervals reflect the small sample size and highlight
the need for further work with larger numbers of patients.
The authors also acknowledge that only 54 patients of the 73 patients recruited in the study
provided blood samples. This discrepancy may be explained by a number of reasons. Firstly,
some patients did not proceed to surgery owing to unavailability of a hospital bed or the
Bacteraemia and TURP
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anaesthetist deeming the patient not fit for surgery. Secondly, for the patients who proceeded
to surgery, the principal investigator was unable to gain adequate venous access to obtain the
required blood samples.
Conclusion
We have demonstrated a high rate of bacteraemia in patients undergoing TURP that was asso-
ciated to the prostatic surgery rather than urethral catheter manipulations. Bacteraemia
occurred in spite of antimicrobial prophylaxis. A range of human pathogens was identified
including several known to cause chronic infections, prostatitis and infective endocarditis. The
association between peri-TURP bacteraemia and prostatic adenocarcinoma and inflammation
raises the possibility of bacterial involvement in the pathogenesis of both bladder outflow
obstruction and prostate adenocarcinoma. This warrants further investigation.
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